Brown Brothers Harriman & CO Dexcom Inc Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Dexcom Inc stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 3,930 shares of DXCM stock, worth $342,106. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,930

Previous 4,283 8.24%

Holding current value

$342,106

Previous $485,000 45.77%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $22,592 - $40,969	-353 Reduced 8.24%	3,930 $263,000
Q2 2024 Aug 09, 2024	SELL	$110.31 - $140.45 $154,875 - $197,191	-1,404 Reduced 24.69%	4,283 $485,000
Q1 2024 May 10, 2024	BUY	$114.22 - $140.1 $80,867 - $99,190	708 Added 14.22%	5,687 $788,000
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $29,441 - $48,422	-390 Reduced 7.26%	4,979 $617,000
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $17,212 - $27,586	200 Added 3.87%	5,369 $500,000
Q2 2023 Aug 07, 2023	BUY	$112.47 - $130.98 $12,484 - $14,538	111 Added 2.19%	5,169 $664,000
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $8,840 - $10,448	85 Added 1.71%	5,058 $587,000
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $250,181 - $361,140	2,944 Added 145.1%	4,973 $563,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $18,094 - $22,320	237 Added 13.23%	2,029 $163,000
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $91,854 - $179,534	1,351 Added 306.35%	1,792 $134,000
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $4,704 - $6,509	-50 Reduced 10.18%	441 $226,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $3,116 - $3,907	24 Added 5.14%	491 $264,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $2,774 - $3,722	26 Added 5.9%	467 $255,000
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $22,554 - $27,860	266 Added 152.0%	441 $158,000
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $28,653 - $33,885	-300 Reduced 63.16%	175 $72,000
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $1,504 - $2,528	-24 Reduced 4.81%	475 $193,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1,146 - $1,815	24 Added 5.05%	499 $134,000
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $1,135 - $1,775	-31 Reduced 6.13%	475 $104,000
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $888 - $1,095	25 Added 5.2%	506 $76,000
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $8,519 - $11,909	306 Added 174.86%	481 $72,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $6,315 - $8,590	-225 Reduced 56.25%	175 $21,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $2,699 - $3,736	100 Added 33.33%	400 $48,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $7,005 - $11,016	300 New	300 $43,000
Q1 2018 May 14, 2018	SELL	$13.06 - $18.54 $783 - $1,112	-60 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $667 - $922	60	60 $3,000

Others Institutions Holding DXCM

# of Institutions

1,024

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.61M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Dexcom Inc Transaction History